Old Mission Capital’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Old Mission Capital’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48,440	Closed	-$1.3M	–	1305
2021 Q1	$1.3M	Buy	+48,440	New	+$1.39M	0.07%	304

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Old Mission Capital's LDRS Position: Q2 2021 in Review

Old Mission Capital sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q2 2021, closing a stake of 48,440 shares — an estimated $1.3M sold.

Old Mission Capital first reported a position in LDRS in Q1 2021 and held it in 1 quarter. The position peaked at $1.3M in Q1 2021. 3 funds tracked by Wall St. Rank hold LDRS as of Q2 2021.

Old Mission Capital reported no remaining Innovator IBD ETF Leaders ETF position as of Q2 2021 after selling out during the quarter.
Old Mission Capital sold 48,440 Innovator IBD ETF Leaders ETF shares in Q2 2021, an estimated $1.3M.
Old Mission Capital first reported a position in Innovator IBD ETF Leaders ETF in Q1 2021 and held it in 1 quarter.
Old Mission Capital's Innovator IBD ETF Leaders ETF position peaked at $1.3M in Q1 2021.
3 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q2 2021.

Based on Old Mission Capital's 13F filing for Q2 2021, filed 13 Aug 2021.